SCHEMBL7521626

SCHEMBL7521626

CSCC[C@H](NC(C)=O)C(=O)NCc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ANPEP P15144 1/20 0.69
▸ CA12 O43570 1/20 0.65
▸ CA1 P00915 1/20 0.65
▸ CA2 P00918 1/20 0.65
▸ CA3 P07451 1/20 0.65
▸ CA4 P22748 1/20 0.65
▸ CA6 P23280 1/20 0.65
▸ CA5A P35218 1/20 0.65
▸ CA7 P43166 1/20 0.65
▸ CACNA1C Q13936 1/20 0.65
▸ SCN9A Q15858 1/20 0.65
▸ CA9 Q16790 1/20 0.65
▸ CA13 Q8N1Q1 1/20 0.65
▸ CA14 Q9ULX7 1/20 0.65
▸ CA5B Q9Y2D0 1/20 0.65
▸ FNTA P49354 1/20 0.57
▸ FNTB P49356 1/20 0.57
▸ TSHR P16473 1/20 0.55
▸ EGFR P00533 1/20 0.54
▸ SRC P12931 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7521630 1.00 ANPEP (0.69) ANPEPCA12CA1CA2CA3
SCHEMBL9821905 0.91 ANPEP (0.65) ANPEPCA12CA1CA2CA3
SCHEMBL24301278 0.87 ANPEP (0.54) ANPEPCA12CA1CA2CA3
SCHEMBL6236631 0.86 ANPEP (0.61) ANPEPCA12CA1CA2CA3
SCHEMBL22905316 0.85 CA1 (0.70) ANPEPCA12CA1CA2CA3
SCHEMBL1895974 0.85 CA1 (0.70) ANPEPCA12CA1CA2CA3
SCHEMBL9366412 0.83 ANPEP (0.56) ANPEPCA12CA1CA2CA3
SCHEMBL31291804 0.83 CTSK (0.65) ANPEPCA2CTSSCTSK
SCHEMBL8836882 0.82 GNPAT (0.61) ANPEPFNTAFNTB
SCHEMBL47275 0.81 CA12 (0.74) ANPEPCA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0194464-B1 AMINO ACID DERIVATIVES AND USE THEREOF FOR THE PREPARATION OF AN ANTICONVULSANT Research Corporation Technologies, Inc. (a Delaware corp.) (US) 1991-04-03 — — EP claimed
EP-0194464-A1 Amino acid derivatives and use thereof for the preparation of an anticonvulsant Research Corporation Technologies, Inc. (a Delaware corp.) (US) 1986-09-17 — — EP claimed
EP-0400440-B1 Amino acid derivative anticonvulsant RES CORP TECHNOLOGIES INC (US) 2002-03-13 — — EP disclosed
US-5654301-A Lacosamide FDA Orange book listed patent RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1997-08-05 — — US disclosed
US-5378729-A Diamide derivatives RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1995-01-03 — — US disclosed
EP-0592490-A4 AMINO ACID DERIVATIVE ANTICONVULSANT RES CORP TECHNOLOGIES INC (US) 1994-08-17 — — EP disclosed
EP-0592490-A1 AMINO ACID DERIVATIVE ANTICONVULSANT RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1994-04-20 — — EP disclosed
EP-0263506-B1 ANTICONVULSANT COMPOSITION CONTAINING AMINO ACID DERIVATIVE AND USE OF SAID AMINO ACID DERIVATIVE RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-08-04 — — EP disclosed
WO-1992021648-A1 AMINO ACID DERIVATIVE ANTICONVULSANT RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1992-12-10 — — WO disclosed
EP-0194464-B1 AMINO ACID DERIVATIVES AND USE THEREOF FOR THE PREPARATION OF AN ANTICONVULSANT Research Corporation Technologies, Inc. (a Delaware corp.) (US) 1991-04-03 — — EP disclosed
WO-1990015069-A2 AMINO ACID DERIVATIVE ANTICONVULSANT RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1990-12-13 — — WO disclosed
EP-0400440-A1 Amino acid derivative anticonvulsant RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1990-12-05 — — EP disclosed
EP-0263506-A2 Anticonvulsant composition containing amino acid derivative and use of said amino acid derivative RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1988-04-13 — — EP disclosed
EP-0194464-A1 Amino acid derivatives and use thereof for the preparation of an anticonvulsant Research Corporation Technologies, Inc. (a Delaware corp.) (US) 1986-09-17 — — EP disclosed
Send feedback